Acute lymphocytic leukaemia recurrent and Memory loss

Summary:

Memory loss is found among people with Acute lymphocytic leukaemia recurrent, especially for people who are male, 60+ old.

The study analyzes which people have Memory loss with Acute lymphocytic leukaemia recurrent. It is created by eHealthMe based on reports of 19 people who have Acute lymphocytic leukaemia recurrent from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Acute lymphocytic leukaemia recurrent?

Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent) is found to be associated with 165 drugs and 227 conditions by eHealthMe. Check the latest studies of Acute lymphocytic leukaemia recurrent.

What is Memory loss?

Memory loss is found to be associated with 2,726 drugs and 4,377 conditions by eHealthMe. Check the latest studies of Memory loss.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 26, 2026

19 people who have Acute Lymphocytic Leukaemia Recurrent and Memory Loss are studied.

Would you have Memory loss when you have Acute lymphocytic leukaemia recurrent?

Gender of people who have Acute Lymphocytic Leukaemia Recurrent and experienced Memory Loss *:

female: 44.44 %
male: 55.56 %

Age of people who have Acute Lymphocytic Leukaemia Recurrent and experienced Memory Loss *:

Common co-existing conditions for these people *:

Pain: 3 people, 15.79%
Nausea And Vomiting: 2 people, 10.53%
Nausea (feeling of having an urge to vomit): 2 people, 10.53%
High Blood Pressure: 2 people, 10.53%
Fungal Infection: 2 people, 10.53%
Fever: 2 people, 10.53%
Constipation: 2 people, 10.53%
Blood Pressure Abnormal: 2 people, 10.53%
Insomnia (sleeplessness): 1 person, 5.26%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.26%

Common drugs taken by these people *:

Common symptoms for these people *:

Speech Impairment (Adult) (inability to speak (adult)): 9 people, 47.37%
Confusional State: 9 people, 47.37%
Fever: 6 people, 31.58%
Hypotension (abnormally low blood pressure): 5 people, 26.32%
Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 26.32%
Fatigue (feeling of tiredness): 5 people, 26.32%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 4 people, 21.05%
Malignant Neoplasm Progression (cancer tumour came back): 4 people, 21.05%
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system): 4 people, 21.05%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 3 people, 15.79%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Memory loss?

- Check whether Memory loss is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Acute lymphocytic leukaemia recurrent (4,824 reports)
Memory loss (244,444 reports)

All the drugs that are associated with Memory loss:

Memory loss (2,726 drugs)

All the conditions that are associated with Memory loss:

Memory loss (4,377 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Memory loss and Acute lymphocytic leukaemia recurrent, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.